000281677 001__ 281677
000281677 005__ 20220930130057.0
000281677 0247_ $$2doi$$a10.1155/2015/569052
000281677 0247_ $$2ISSN$$a2314-6133
000281677 0247_ $$2ISSN$$a2314-6141
000281677 0247_ $$2Handle$$a2128/9799
000281677 0247_ $$2WOS$$aWOS:000364067900001
000281677 0247_ $$2altmetric$$aaltmetric:4746053
000281677 0247_ $$2pmid$$apmid:26568958
000281677 037__ $$aFZJ-2016-01365
000281677 041__ $$aEnglish
000281677 082__ $$a610
000281677 1001_ $$0P:(DE-Juel1)131869$$aHauptmann, Christian$$b0$$eCorresponding author$$ufzj
000281677 245__ $$aAcoustic Coordinated Reset Neuromodulation in a Real Life Patient Population with Chronic Tonal Tinnitus
000281677 260__ $$aNew York [u.a.]$$bHindawi$$c2015
000281677 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1454314178_19494
000281677 3367_ $$2DataCite$$aOutput Types/Journal article
000281677 3367_ $$00$$2EndNote$$aJournal Article
000281677 3367_ $$2BibTeX$$aARTICLE
000281677 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000281677 3367_ $$2DRIVER$$aarticle
000281677 520__ $$aPurpose. Primary tinnitus has a severe negative influence on the quality of life of a significant portion of the general population. Acoustic coordinated reset neuromodulation is designed to induce a long-lasting reduction of tinnitus symptoms. To test acoustic coordinated reset neuromodulation as a treatment for chronic, tonal tinnitus under real life conditions, an outpatient study “RESET Real Life” was commissioned by ANM GmbH. Herein we present the results of this study. Methods. In a prospective, open-label, nonrandomized, noncontrolled multicenter clinical study with 200 chronic tinnitus patients, tinnitus questionnaire TBF-12 and Global Clinical Improvement-Impression Scale (CGI-I7) are used to study the safety and efficacy of acoustic coordinated reset neuromodulation. 189 patients completed the last 12-month visit, 11 patients dropped out (8 because of nontreatment related reasons; 2 because tinnitus did not change; and 1 because tinnitus got louder). Results. Acoustic coordinated reset neuromodulation caused a statistically and clinically significant decrease in TBF-12 scores as well as in CGI-I7 after 12 months of therapy under real life conditions. There were no persistent adverse events reported that were related to the therapy. Conclusion. The field study “RESET Real Life” provides evidence for safety and efficacy of acoustic coordinated reset neuromodulation in a prospective, open-label, real life setting.
000281677 536__ $$0G:(DE-HGF)POF2-89572$$a89572 - (Dys-)function and Plasticity (POF2-89572)$$cPOF2-89572$$fPOF II T$$x0
000281677 536__ $$0G:(DE-Juel-1)BHG_T/Z4000.01.13_19022015$$aBHG-FZJ - Zusammenarbeits- und Lizenzoptionsvereinbarung zwischen Brook Henderson Group Limited und Forschungszentrum Jülich GmbH (BHG_T/Z4000.01.13_19022015)$$cBHG_T/Z4000.01.13_19022015$$x1
000281677 588__ $$aDataset connected to CrossRef
000281677 7001_ $$0P:(DE-HGF)0$$aStröbel, Armin$$b1
000281677 7001_ $$0P:(DE-HGF)0$$aWilliams, Mark$$b2
000281677 7001_ $$0P:(DE-HGF)0$$aPatel, Nitesh$$b3
000281677 7001_ $$0P:(DE-HGF)0$$aWurzer, Hannes$$b4
000281677 7001_ $$0P:(DE-HGF)0$$avon Stackelberg, Tatjana$$b5
000281677 7001_ $$0P:(DE-HGF)0$$aBrinkmann, Uwe$$b6
000281677 7001_ $$0P:(DE-HGF)0$$aLangguth, Berthold$$b7
000281677 7001_ $$0P:(DE-Juel1)131884$$aTass, Peter A.$$b8$$ufzj
000281677 773__ $$0PERI:(DE-600)2698540-8$$a10.1155/2015/569052$$gVol. 2015, p. 1 - 8$$p569052$$tBioMed research international$$v2015$$x2314-6141$$y2015
000281677 8564_ $$uhttps://juser.fz-juelich.de/record/281677/files/569052.pdf$$yOpenAccess
000281677 8564_ $$uhttps://juser.fz-juelich.de/record/281677/files/569052.gif?subformat=icon$$xicon$$yOpenAccess
000281677 8564_ $$uhttps://juser.fz-juelich.de/record/281677/files/569052.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
000281677 8564_ $$uhttps://juser.fz-juelich.de/record/281677/files/569052.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
000281677 8564_ $$uhttps://juser.fz-juelich.de/record/281677/files/569052.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
000281677 8564_ $$uhttps://juser.fz-juelich.de/record/281677/files/569052.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000281677 8767_ $$92015-01-13$$d2015-01-13$$eAPC$$jZahlung erfolgt$$lKK: Mittermaier$$zUSD 2.000,-
000281677 909CO $$ooai:juser.fz-juelich.de:281677$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000281677 915__ $$0LIC:(DE-HGF)CCBY3$$2HGFVOC$$aCreative Commons Attribution CC BY 3.0
000281677 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000281677 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000281677 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBIOMED RES INT : 2014
000281677 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000281677 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000281677 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000281677 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000281677 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000281677 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000281677 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000281677 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000281677 9141_ $$y2015
000281677 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131869$$aForschungszentrum Jülich GmbH$$b0$$kFZJ
000281677 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131884$$aForschungszentrum Jülich GmbH$$b8$$kFZJ
000281677 9131_ $$0G:(DE-HGF)POF2-89572$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$v(Dys-)function and Plasticity$$x0
000281677 9201_ $$0I:(DE-Juel1)INM-7-20090406$$kINM-7$$lGehirn & Verhalten$$x0
000281677 9801_ $$aUNRESTRICTED
000281677 9801_ $$aFullTexts
000281677 980__ $$ajournal
000281677 980__ $$aVDB
000281677 980__ $$aUNRESTRICTED
000281677 980__ $$aI:(DE-Juel1)INM-7-20090406
000281677 980__ $$aAPC